Roflumilast (daliresp): a novel phosphodiesterase-4 inhibitor for the treatment of severe chronic obstructive pulmonary disease.

Article Details

Citation

Copy to clipboard

Baye J

Roflumilast (daliresp): a novel phosphodiesterase-4 inhibitor for the treatment of severe chronic obstructive pulmonary disease.

P T. 2012 Mar;37(3):149-61.

PubMed ID

22605906 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Drugs

Roflumilast

Drug Enzymes

Drug	Enzyme	Kind	Organism	Pharmacological Action	Actions
Roflumilast	Cytochrome P450 3A4	Protein	Humans	No	Substrate	Details